Kevin D. Bunker

Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib

Qinhua Huang, Ted W. Johnson, Simon Bailey et al. · Journal of Medicinal Chemistry · 2014 · 115 citations · Full text

Aminopyridine 8E, Tumor Biology, Kinase Domain +14

Scalable Synthesis of 1-Bicyclo[1.1.1]pentylamine via a Hydrohydrazination Reaction

Kevin D. Bunker, Neal W. Sach, Qinhua Huang et al. · Organic Letters · 2011 · 70 citations

Discovery of ZN-c3, a Highly Potent and Selective Wee1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of Cancer

Peter Q. Huang, Brant C. Boren, Sayee G. Hegde et al. · Journal of Medicinal Chemistry · 2021 · 61 citations · Full text

Sulfoxide Carbon−Sulfur Bond Activation

J. M. O’Connor, Kevin D. Bunker, Arnold L. Rheingold et al. · Journal of the American Chemical Society · 2005 · 25 citations

X-ray Crystallography, Inorganic Chemistry, Chemical Engineering +12

Abstract 4373: Discovery of ZN-c5, a novel potent and oral selective estrogen receptor degrader

Ahmed A. Samatar, Jiali Li, Sayee G. Hegde et al. · Cancer Research · 2020 · 20 citations

Breast Oncology, Chemoprevention Strategy, Estrogen Receptor +23